Cambridge, United Kingdom

John Colm O'Toole

This inventor holds 1 USPTO granted patent. Top assignee: Warner-Lambert Company. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Colm O'Toole. Retrieved from https://idiyas.com/inventor/john-colm-o-toole

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John Colm O'Toole: Innovator in CNS Agents

Introduction

John Colm O'Toole is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target central nervous system disorders. His work has the potential to impact the treatment of various mental health conditions.

Latest Patents

O'Toole holds a patent for "Aromatic amides," which includes aromatic and heteroaromatic amides that are useful as CNS agents. These compounds are designed to treat pain, depression, anxiety, seizures, and schizophrenia. His innovative approach to these chemical structures showcases his expertise in medicinal applications.

Career Highlights

Throughout his career, O'Toole has been associated with Warner-Lambert Company, where he has contributed to research and development in pharmaceutical sciences. His work has led to advancements in the understanding and treatment of CNS-related conditions.

Collaborations

O'Toole has collaborated with notable colleagues, including Justin Stephen Bryans and David Christopher Horwell. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

John Colm O'Toole's contributions to the field of medicinal chemistry, particularly through his patent on aromatic amides, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of CNS disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…